期刊文献+

精液源性病毒感染增强因子SEVI-HIV性传播中的重要因素 被引量:1

Semen-derived Enhancer of Viral Infection-a Key Factor in Sexual Transmission of HIV
原文传递
导出
摘要 精液源性病毒增强因子(Semen-derived enhancer of viral infection,SEVI)是前列腺酸性磷酸酶(Prostatic acidphosphatase,PAP)位于PAP248-286的多肽片段,可增强人免疫缺陷病毒(Human immunodeficiency virus,HIV)的感染性。SEVI促进HIV感染的作用机制包括:①富含阳离子氨基酸残基的SEVI能通过静电作用降低HIV病毒颗粒与靶细胞之间的静电排斥;②SEVI在人体液中呈无序状态,利于病毒与靶细胞膜相互作用;③SEVI直接捕获HIV颗粒,提高病毒在靶细胞表面沉降速度,促进病毒与靶细胞的吸附和融合。目前已发现能抑制SEVI活性的物质包括:绿茶来源的EGCG(没食子儿茶素没食子酸酯)、氨基喹啉类小分子化合物Surfen、ThT类似物BTA-EG6等,能通过阻断HIV与SEVI结合或阻止其淀粉样纤维的形成,降低SEVI的病毒感染增强作用。研究SEVI的生物学特性及作用机制对防治HIV感染具有较为重要的指导意义。 Semen-derived enhancer of viral infection(SEVI) is a peptide fragment(PAP248-286) from prostatic acid phosphatase(PAP),which can enhance human immunodeficiency virus infection.The mechanisms of SEVI include: ① SEVI with several cationic amino acid residues reduced electrostatic repulsion between HIV virus and the target cells;②The disorder state of SEVI in the human body fluids was helpful to the interaction between virus and the target cell membranes;③SEVI could capture HIV particles directly and speed the velocity of virus on the surface of the target cells and improve adsorption and fusion.Currently,the substances of inhibiting SEVI activity include: EGCG from green tea,small molecule compound of aminoquinoline Surfen,ThT analogs BTA-EG6.Those compounds might block the combination of HIV and SEVI or prevent the formation of amyloid fibers,and then reduce the enhancement of SEVI.The studies on the biological characteristics and mechanisms of SEVI have a big benefit for the prevention and treatment of HIV infection.
出处 《病毒学报》 CAS CSCD 北大核心 2012年第1期84-88,共5页 Chinese Journal of Virology
基金 国家自然科学基金资助(30801412)
关键词 精液源性病毒增强因子 HIV性传播 淀粉样纤维 静电斥力 Semen-derived enhancer of viral infection HIV sexual transmission Amyloid fibrils Electrostatic repulsion
  • 相关文献

参考文献22

  • 1Richman D D.Introduction:challenges to finding a curefor HIV infection[J].Curr Opin HIV AIDS,2011,6(1):1-3.
  • 2UNAIDS.2010Report on the global AIDS epidemic[DB/OL].http://www.unaids.org/globalreport/Global_report.htm.
  • 3Dimitrov D S,Willey R L,Sato H,et al.Quantitationof human immunodeficiency virustype 1infection kinetics[J].J Virol,1993,67:2182-2190.
  • 4Münch J,Rücker E,Stndker L,et al.Semen-derivedamyloid fibrils drastically enhance HIV infection[J].Cell,2007,131(6):1059-1071.
  • 5Roan N R,Greene W C.A seminal finding for under-standing HIV transmission[J].Cell,2007,131(6):1044-1046.
  • 6Yankner B A,Duffy L K,Kirschner D A,et al.Neuro-trophic and neurotoxic effect of amyloidβ-protein:rever-sal by tachykinin neuropeptides[J].Science,1990,250(4978):279-282.
  • 7Esiri M M,Biddolph S C,Morris C S.Prevalence ofAlzheimer plaques in AIDS[J].J Neurol NeurosurgPsychiatry,1998,65,29-33.
  • 8Wojtowicz W M,Farzan M,Joyal J L,et al.Stimula-tion of enveloped virus infection by beta-amyloid fibrils[J].J Biol Chem,2002,277(38):35019-35024.
  • 9Davis H E,Resinski M,Morgan J R,et a1.Chargedpolymers modulate retrovirus transduction via membranecharge neutralslion and virus aggregation[J].Biophys J,2004,86(2):1234-1242.
  • 10Roan N R,MOnth J,Arhei N,et a1.The cationicproperties of SEVI underlie its ability to enhance humanimmunodeficiency virus infection[J].J Virol,2009,83(1):73-80.

二级参考文献16

  • 1Kiasse PJ,Shattock R,Moore JP.Antiretroviral drug-based mi-crobicides to prevent HIV-1 sexual transmission[J].Annu RevMed,2008,59:455-471.
  • 2Galvin SR,Cohen MS.The role of sexually transmitted diseasesin HIV transmission[J].Nat Rev Microbiol,2004,2(1):33-42.
  • 3Munch J,RUcker E,Standker L,et al.Semen-derived amyloidfibrils drastically enhance HIV infection[J].Cell,2007,131(6):1059-1071.
  • 4R(o)nnberg L,Vihko P,Sajanti E,et al.Clomiphene citrate ad-ministration to normogonadotropic subfertile men:blood hormone changes and activation of acid phosphalase in seminal fluid[J].Int J Androl,1981,4(3):372-378.
  • 5Roan NR,Munch J,Arhel N,et al.The cationic properties of SEVI underlie its ability to enhance human immunodeficiency virus infection[J].J Virol,2009,83(1):73-8O.
  • 6Davis HE,Rosinski M,Morgan JR,et al.Charged polymers modulate retrovirus transduction via membrane charge neutralization and virus aggregation[J].Biophys J,2004,86 (2):1234-1242.
  • 7Appay V,Rowland-Jones SL.RANTES:a versatile and controversial chemokine[J].Trends Immunol,2001,22(2):83-87.
  • 8Roan NR,Greene WC.A seminal finding for understanding HIV transmission[J].Cell,2007,131(6):1044-1046.
  • 9Hong S,Klein EA,Das Gupta J,et al.Fibrils of prostatic acid phosphatase fragments boost infections with XMRV (xenotropic murine leukemia virus-related virus),a human retrovirus associated with prostate cancer[J].J Virol,2009,83 (14):6995-7003.
  • 10Knouf EC,Metzger MJ,Mitchell PS,et al.Multiple integrated copies and high-level production of the human retrovirus XMRV (xenotropic murine leukemia virus-related virus) from 22Rvlprostate carcinoma cells[J].J Virol,2009,83(14):7353-7356.

共引文献1

同被引文献25

  • 1Rusert P, Fischer M, Joos B, et al. Quantification of infectious HIV-1 plasma viral load using a boosted in vitro infection protocol. Virology, 2004, 326 (1) : 113-129.
  • 2Royce RA, Sena A, Cates W Jr, et al. Sexual transmission of HIV. N Engl J Med, 1997, 336 (15) : 1072-1078.
  • 3Ceballos A, Remes Lenicov F, Sabatte J, et al. Spermatozoa cap- ture HIV-1 through heparan sulfate and efficiently transmit the vi- res to dendritic cells. J Exp Med, 2009, 206 (12) : 2717-2133.
  • 4Doncel GF, Joseph T, Thurman AR. Role of semen in HIV-1 transmission: inhibitor or facilitator? Am J Reprod Immunol, 2011, 65 (3) : 292-301.
  • 5Kalichman SC, Di Berto G, Eaton L. Human immunodeficiency virus viral load in blood plasma and semen: review and implica- tions of empirical findings. Sex Transm Dis, 2008, 35 ( 1 ) : 55- 60.
  • 6Stekler J, Sycks BJ, Holte S, et al. HIV dynamics in seminal plasma during primary HIV infection. AIDS Res Hum Retrovirus- es, 2008, 24(10) : 1269-1274.
  • 7Politch JA, Mayer KH, Welles SL, et al. Highly active antiretro- viral therapy does not completely suppress HIV in semen of sexual- ly active HIV-infected men who have sex with men. AIDS, 2012, 26(12) : 1535-1543.
  • 8Gilliam BL, Dyer JR, Fiscus SA, et al. Effects of reverse tran- scriptase inhibitor therapy on the HIV-1 viral burden in semen. J Acquir Immune Defic Syndr Hum Retrovirol, 1997, 15 ( 1 ) : 54- 60.
  • 9Taylor S, Boffito M and Vernazza PL. Antiretroviral therapy to re- duce the sexual transmission of HIV. J HIV Ther, 2003, 8 ( 3 ) :55 -66.
  • 10Lambert-Niclot S, Tubiana R, Beaudoux C, et al. Detection of HIV-1 RNA in seminal plasma samples from treated patients with undetectable HIV-1 RNA in blood plasma on a 2002-2011 survey. AIDS, 2012, 26(8) : 971-975.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部